|Articles|December 20, 2001
FDA Final Rule
Author(s)BioPharm International Editors
FDA final rule requiring foreign drug and biologics manufacturers to register their operations and products. Takes effect 11 Feb 2002
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
3
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
4
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
5
